Literature DB >> 22469665

Dyspnea prevalence, trajectories, and measurement in critical care and at life's end.

Margaret L Campbell1.   

Abstract

PURPOSE OF REVIEW: Dyspnea is a multidimensional response to an asphyxial threat that heralds respiratory failure. A clinician's ability to treat dyspnea warrants understanding the prevalence, burden, trajectories, and measurement across chronic conditions and exacerbations. This review focuses on two contexts: the intensive care unit and the near death stage of illness. RECENT
FINDINGS: Dyspnea is the most distressing symptom experienced by critically ill patients at risk for dying. New longitudinal studies reveal varying dyspnea trajectories over time and by diagnosis. Patients with noncancer diagnoses, particularly chronic obstructive pulmonary disease, experience severe dyspnea for months before death, whereas patients with cancer even without apparent cardiorespiratory disease have an escalation of dyspnea near death. The sickest patients and those who are cognitively impaired or unconscious are not represented because self-report measures are used. Thus, dyspnea is underrepresented in most end-of-life cohorts. In most data, the Numeric Rating Scale for the intensity of breathlessness, while unidimensional, is the most valid measure for palliative care because of its simplicity. Use of the Respiratory Distress Observation Scale in future studies will permit the inclusion of patients who are unable to self-report dyspnea.
SUMMARY: In summary, new evidence is demonstrating the high prevalence and distress associated with dyspnea among critically ill patients and patients near death.

Entities:  

Mesh:

Year:  2012        PMID: 22469665     DOI: 10.1097/SPC.0b013e328352b67f

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  4 in total

1.  Incidence and Risk Model Development for Severe Tachypnea Following Terminal Extubation.

Authors:  Corey R Fehnel; Miguel Armengol de la Hoz; Leo A Celi; Margaret L Campbell; Khalid Hanafy; Ala Nozari; Douglas B White; Susan L Mitchell
Journal:  Chest       Date:  2020-04-28       Impact factor: 9.410

2.  The safety and efficacy of systemic versus catheter-based therapies: application of a prognostic model by a pulmonary embolism response team.

Authors:  Jean-Pierre Iskandar; Essa Hariri; Christopher Kanaan; Nicholas Kassis; Hayaan Kamran; Denise Sese; Colin Wright; Mark Marinescu; Scott J Cameron
Journal:  J Thromb Thrombolysis       Date:  2021-09-29       Impact factor: 2.300

3.  Danish translation and linguistic validation of the multidimensional dyspnea profile.

Authors:  Charlotte Sandau Bech; Vibeke Noerholm; Dorthe Gaby Bové; Ingrid Poulsen
Journal:  Eur Clin Respir J       Date:  2021-03-30

Review 4.  Palliative care in the ICU: relief of pain, dyspnea, and thirst--a report from the IPAL-ICU Advisory Board.

Authors:  Kathleen Puntillo; Judith Eve Nelson; David Weissman; Randall Curtis; Stefanie Weiss; Jennifer Frontera; Michelle Gabriel; Ross Hays; Dana Lustbader; Anne Mosenthal; Colleen Mulkerin; Daniel Ray; Rick Bassett; Renee Boss; Karen Brasel; Margaret Campbell
Journal:  Intensive Care Med       Date:  2013-11-26       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.